logo

For the Inventor, By the Inventor

Sant Cugat del Vallès, Spain

Interquim, S.a.


USPTO Granted Patents = 22

% Expired Patents = 36.4



Trademarks = 5

Forward Citations = 29

Loading Chart...
Loading Chart...

28 inventors (with patents filed for the assignee):

goldMedal Francisco Marquillas Olondriz (13 out of 17 patents)

silverMedal Santiago Nonell Marrugat (4 out of 4 patents)

bronzeMedal Ricardo Miralles Bacete (4 out of 4 patents)

4.  Marta Pomares Marco (4 out of 4 patents)

5.  Xavier Berzosa Rodríguez (3 out of 3 patents)

6.  Joan Sallares (3 out of 3 patents)

7.  Francisco Javier López Cremades (2 out of 2 patents)

8.  Adaya Gallardo Sanchez (2 out of 2 patents)

9.  Jonathan Paul Taylor (2 out of 3 patents)

10.  Adaya Gallardo Sánchez (2 out of 2 patents)

11.  Christopher John Althorpe (2 out of 18 patents)

12.  Francisco De Asís Marquillas Olondriz (2 out of 2 patents)

13.  Juan Sallares Rosell (1 out of 2 patents)

14.  Francisco Javier Crespo Montero (1 out of 4 patents)

15.  Joaquim Balcells Terés (1 out of 1 patent)


22 patents:

1. 12312315 - Process for the preparation of aripiprazole lauroxil (2025-05-27),
2. 12172979 - Process for the preparation of aripiprazole lauroxil (2024-12-24),
3. 11286250 - Process for preparing and purifying a LFA-1 antagonist (2022-03-29),
4. 10723721 - Process for preparing and purifying the LFA-1 antagonist lifitegrast (2020-07-28),
5. 10711025 - Process for the preparation of diosmin (2020-07-14),
6. 10328017 - Silyl polymeric benzoic acid ester compounds, uses, and compositions thereof (2019-06-25),
7. 10287310 - Process for the preparation of diosmin (2019-05-14),
8. 10195373 - Inhaler (2019-02-05),
9. 10159265 - Feed composition for reducing ruminant methanogenesis (2018-12-25),
10. 10087200 - Silylated imine and carbamate polymeric benzoate compounds, uses, and compositions thereof (2018-10-02),
11. 9867770 - Silyl polymeric benzoic acid ester compounds, uses, and compositions thereof (2018-01-16),
12. 9815771 - Method for the synthesis of mirabegron and its derivatives (2017-11-14),
13. 9365544 - Process for the preparation of intermediates for the synthesis of Dabigatran Etexilate, and crystalline forms of said intermediates (2016-06-14),
14. 9321726 - Process for preparing roflumilast (2016-04-26),
15. 9157166 - Process for preparing the crystalline form A of (2-[3-cyano-4-(2-I-butoxy)phenyl]-4-methyl-5-thiazole-carboxylic acid (febuxostat) (2015-10-13),
Company Overview
Interquim, S.A. is a prominent chemical company based in Sant Cugat del Vallès, Spain, specializing in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The organization focuses on providing innovative solutions for the pharmaceutical industry, emphasizing quality and compliance with regulatory standards. With a strong commitment to research and development, Interquim aims to advance therapeutic options and enhance the efficacy of medications, serving clients across various global markets.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

22 Patents

#1 in Sant Cugat del Vallès

#90 in Spain

#28,782 in the World

Sant Cugat del Vallès, ES
Sant Cugat del Vallès, Spain

Interquim, S.a.

Forward Citations = 29

28 inventors:

goldMedal Francisco Marquillas Olondriz (13 out of 17 patents)

silverMedal Santiago Nonell Marrugat (4 out of 4 patents)

bronzeMedal Ricardo Miralles Bacete (4 out of 4 patents)

4.  Marta Pomares Marco (4 out of 4 patents)

5.  Xavier Berzosa Rodríguez (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Interquim, S.a.. Retrieved from https://idiyas.com/company/interquim-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…